Skip to main
  1. Stocks
  2. HCA Healthcare
  3. Forecast
HCA

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Healthcare (HCA) Analyst Ratings

Based on 22 analyst ratings
Buy
Strong Buy 32%
Buy 36%
Hold 27%
Sell 5%
Strong Sell 0%

Bulls say

HCA Healthcare is supported by unmatched scale as the largest integrated acute-care provider in the U.S., with 190 hospitals and more than 2,500 outpatient facilities across 19 states and the U.K., which strengthens its competitive moat and market access. Its 3Q26 core adjusted EBITDA growth of about 10%, expected FY26 EBITDA of $15.90B, and favorable managed care pricing reflect resilient demand, strong rate positioning, and disciplined cost control despite Medicaid supplemental payment headwinds. Robust free cash flow, roughly $4.5B of operating cash flow, and ample balance-sheet capacity for buybacks, capex, and M&A further reinforce a positive long-term fundamental outlook.

Bears say

HCA Healthcare is facing a fundamentally negative setup because its earnings are exposed to worsening payor mix, with HIX-to-uninsured migration and the expiration of enhanced subsidies pressuring reimbursement while government and managed-care rates lag inflation. Competitive intensity, tighter clinical labor supply, and higher staffing, professional fee, and supply costs threaten margins and cash flow, even as management already flagged FY26 HIX headwinds at or above the $1.2 billion high end of guidance. The result is a business that may still show solid volumes, but with elective surgery weakness, regulatory uncertainty, and limited margin protection that can offset operational growth.

HCA Healthcare (HCA) has been analyzed by 22 analysts, with a consensus rating of Buy. 32% of analysts recommend a Strong Buy, 36% recommend Buy, 27% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.

HCA Healthcare (HCA) Analyst Forecast & Price Prediction

Get the latest HCA Healthcare (HCA) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in HCA Healthcare (HCA)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HCA Healthcare (HCA) Forecast

Analysts have given HCA Healthcare (HCA) a Buy based on their latest research and market trends.

According to 22 analysts, HCA Healthcare (HCA) has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $492.14, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $492.14, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HCA Healthcare (HCA)


HCA Healthcare (HCA) Analyst Forecast & Price Prediction

Get the latest HCA Healthcare (HCA) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in HCA Healthcare (HCA)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover HCA stock data and trends